Secreted Human Adipose Leptin Decreases Mitochondrial Respiration in HCT116 Colon Cancer Cells

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Sep 28

PMID 24073224

Citations 15

Authors

Einav Yehuda-Shnaidman

Lili Nimri

Tanya Tarnovscki

Boris Kirshtein

Assaf Rudich

Betty Schwartz

Affiliations

Soon will be listed here.

Abstract

Obesity is a key risk factor for the development of colon cancer; however, the endocrine/paracrine/metabolic networks mediating this connection are poorly understood. Here we hypothesize that obesity results in secreted products from adipose tissue that induce malignancy-related metabolic alterations in colon cancer cells. Human HCT116 colon cancer cells, were exposed to conditioned media from cultured human adipose tissue fragments of obese vs. non-obese subjects. Oxygen consumption rate (OCR, mostly mitochondrial respiration) and extracellular acidification rate (ECAR, mostly lactate production via glycolysis) were examined vis-à-vis cell viability and expression of related genes and proteins. Our results show that conditioned media from obese (vs. non-obese) subjects decreased basal (40%, p<0.05) and maximal (50%, p<0.05) OCR and gene expression of mitochondrial proteins and Bax without affecting cell viability or expression of glycolytic enzymes. Similar changes could be recapitulated by incubating cells with leptin, whereas, leptin-receptor specific antagonist inhibited the reduced OCR induced by conditioned media from obese subjects. We conclude that secreted products from the adipose tissue of obese subjects inhibit mitochondrial respiration and function in HCT116 colon cancer cells, an effect that is at least partly mediated by leptin. These results highlight a putative novel mechanism for obesity-associated risk of gastrointestinal malignancies, and suggest potential new therapeutic avenues.

Citing Articles

Obesity: a perfect storm for carcinogenesis.

Harris B, Macaulay V, Harris D, Klenerman P, Karpe F, Lord S Cancer Metastasis Rev. 2022; 41(3):491-515.

PMID: 36038791 PMC: 9470699. DOI: 10.1007/s10555-022-10046-2.

The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy.

Fagundes Assumpcao J, Pasquarelli-do-Nascimento G, Duarte M, Bonamino M, Magalhaes K J Biomed Sci. 2022; 29(1):12.

PMID: 35164764 PMC: 8842976. DOI: 10.1186/s12929-022-00796-0.

The Adipokine Component in the Molecular Regulation of Cancer Cell Survival, Proliferation and Metastasis.

Umar M, Hassan W, Murtaza G, Buabeid M, Arafa E, Irfan H Pathol Oncol Res. 2021; 27:1609828.

PMID: 34588926 PMC: 8473628. DOI: 10.3389/pore.2021.1609828.

Tumor Metabolic Reprogramming by Adipokines as a Critical Driver of Obesity-Associated Cancer Progression.

Pham D, Park P Int J Mol Sci. 2021; 22(3).

PMID: 33535537 PMC: 7867092. DOI: 10.3390/ijms22031444.

Linking Obesity with Colorectal Cancer: Epidemiology and Mechanistic Insights.

Ye P, Xi Y, Huang Z, Xu P Cancers (Basel). 2020; 12(6).

PMID: 32486076 PMC: 7352519. DOI: 10.3390/cancers12061408.

References

Toyoshima Y, Gavrilova O, Yakar S, Jou W, Pack S, Asghar Z . Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes. Endocrinology. 2005; 146(9):4024-35. DOI: 10.1210/en.2005-0087. View

Collins S, Yehuda-Shnaidman E, Wang H . Positive and negative control of Ucp1 gene transcription and the role of β-adrenergic signaling networks. Int J Obes (Lond). 2010; 34 Suppl 1:S28-33. DOI: 10.1038/ijo.2010.180. View

Zheng Q, Dunlap S, Zhu J, Downs-Kelly E, Rich J, Hursting S . Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival. Endocr Relat Cancer. 2011; 18(4):491-503. PMC: 3197719. DOI: 10.1530/ERC-11-0102. View

Chandra D, Singh K . Genetic insights into OXPHOS defect and its role in cancer. Biochim Biophys Acta. 2010; 1807(6):620-5. PMC: 4681500. DOI: 10.1016/j.bbabio.2010.10.023. View

Schnabele K, Roser S, Rechkemmer G, Hauner H, Skurk T . Effects of adipocyte-secreted factors on cell cycle progression in HT29 cells. Eur J Nutr. 2009; 48(3):154-61. DOI: 10.1007/s00394-009-0775-6. View

Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J . Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res. 2006; 12(5):1447-53. DOI: 10.1158/1078-0432.CCR-05-1913. View

Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A, Saavedra E . Energy metabolism in tumor cells. FEBS J. 2007; 274(6):1393-418. DOI: 10.1111/j.1742-4658.2007.05686.x. View

Bresalier R, Schwartz B, Kim Y, Duh Q, Kleinman H, Sullam P . The laminin alpha 1 chain Ile-Lys-Val-Ala-Val (IKVAV)-containing peptide promotes liver colonization by human colon cancer cells. Cancer Res. 1995; 55(11):2476-80. View

Park J, Euhus D, Scherer P . Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr Rev. 2011; 32(4):550-70. PMC: 3369575. DOI: 10.1210/er.2010-0030. View

10.

Kuan S, Byrd J, Basbaum C, Kim Y . Characterization of quantitative mucin variants from a human colon cancer cell line. Cancer Res. 1987; 47(21):5715-24. View

11.

Schwartz B, Bresalier R, Kim Y . The role of mucin in colon-cancer metastasis. Int J Cancer. 1992; 52(1):60-5. DOI: 10.1002/ijc.2910520113. View

12.

Penta J, Johnson F, Wachsman J, Copeland W . Mitochondrial DNA in human malignancy. Mutat Res. 2001; 488(2):119-33. DOI: 10.1016/s1383-5742(01)00053-9. View

13.

Jaffe T, Schwartz B . Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways. Int J Cancer. 2008; 123(11):2543-56. DOI: 10.1002/ijc.23821. View

14.

Marin-Hernandez A, Gallardo-Perez J, Rodriguez-Enriquez S, Encalada R, Moreno-Sanchez R, Saavedra E . Modeling cancer glycolysis. Biochim Biophys Acta. 2010; 1807(6):755-67. DOI: 10.1016/j.bbabio.2010.11.006. View

15.

Pais R, Silaghi H, Silaghi A, Rusu M, Dumitrascu D . Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol. 2009; 15(41):5141-8. PMC: 2773892. DOI: 10.3748/wjg.15.5141. View

16.

Ronti T, Lupattelli G, Mannarino E . The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf). 2006; 64(4):355-65. DOI: 10.1111/j.1365-2265.2006.02474.x. View

17.

Ward P, Thompson C . Signaling in control of cell growth and metabolism. Cold Spring Harb Perspect Biol. 2012; 4(7):a006783. PMC: 3385956. DOI: 10.1101/cshperspect.a006783. View

18.

Braun S, Bitton-Worms K, LeRoith D . The link between the metabolic syndrome and cancer. Int J Biol Sci. 2011; 7(7):1003-15. PMC: 3164150. DOI: 10.7150/ijbs.7.1003. View

19.

Huysentruyt L, Shelton L, Seyfried T . Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer. Int J Cancer. 2009; 126(1):65-72. DOI: 10.1002/ijc.24649. View

20.

Schmidt H, Siems W, Muller M, Dumdey R, RAPOPORT S . ATP-producing and consuming processes of Ehrlich mouse ascites tumor cells in proliferating and resting phases. Exp Cell Res. 1991; 194(1):122-7. DOI: 10.1016/0014-4827(91)90140-p. View